当前位置:首页 - 行情中心 - 仟源医药(300254) - 财务分析 - 现金流量表

仟源医药

(300254)

  

流通市值:23.57亿  总市值:25.80亿
流通股本:2.27亿   总股本:2.48亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金366,156,378.93180,265,349.65784,575,533.89572,542,194.52
  收到的税费返还1,086,813.441,086,813.44143,992.9-
  收到其他与经营活动有关的现金13,543,051.588,463,432.6556,699,891.0330,930,633.55
  经营活动现金流入小计380,786,243.95189,815,595.74841,419,417.82603,472,828.07
  购买商品、接受劳务支付的现金47,287,758.5923,228,679.48158,459,857.2196,070,596.85
  支付给职工以及为职工支付的现金94,050,773.3150,088,819.64173,544,513.06138,845,629.76
  支付的各项税费61,742,598.4724,197,896.4996,672,359.1770,501,497.62
  支付其他与经营活动有关的现金155,221,703.0287,142,655.12341,802,084.22234,983,113.51
  经营活动现金流出小计358,302,833.39184,658,050.73770,478,813.66540,400,837.74
  经营活动产生的现金流量净额22,483,410.565,157,545.0170,940,604.1663,071,990.33
二、投资活动产生的现金流量:
  收回投资收到的现金--390,817.63-
  取得投资收益收到的现金--2,827,669.48-
  处置固定资产、无形资产和其他长期资产收回的现金净额57,4803,200212,28864,104.02
  处置子公司及其他营业单位收到的现金净额--1,630,157.121,630,157.12
  收到的其他与投资活动有关的现金--1,400,000-
  投资活动现金流入小计57,4803,2006,460,932.231,694,261.14
  购建固定资产、无形资产和其他长期资产支付的现金18,275,121.469,287,259.7251,500,333.7561,065,519.81
  投资支付的现金60,289,231.0460,289,231.04203,230,768.96-
  投资活动现金流出小计78,564,352.569,576,490.76254,731,102.7161,065,519.81
  投资活动产生的现金流量净额-78,506,872.5-69,573,290.76-248,270,170.48-59,371,258.67
三、筹资活动产生的现金流量:
  吸收投资收到的现金--33,346,50033,346,500
  取得借款收到的现金95,000,00083,000,000321,624,008114,624,008
  收到其他与筹资活动有关的现金--1,800,000-
  筹资活动现金流入小计95,000,00083,000,000356,770,508147,970,508
  偿还债务支付的现金77,300,00070,000,000121,751,00078,081,000
  分配股利、利润或偿付利息支付的现金10,163,757.835,001,886.4712,321,406.358,992,692.28
  支付其他与筹资活动有关的现金8,622,4256,080,98027,854,062.3520,122,793.35
  筹资活动现金流出小计96,086,182.8381,082,866.47161,926,468.7107,196,485.63
  筹资活动产生的现金流量净额-1,086,182.831,917,133.53194,844,039.340,774,022.37
五、现金及现金等价物净增加额-57,109,644.77-62,498,612.2217,514,472.9844,474,754.03
  加:期初现金及现金等价物余额149,507,040.96149,507,040.96131,992,567.98131,992,567.98
  期末现金及现金等价物余额92,397,396.1987,008,428.74149,507,040.96176,467,322.01
补充资料:
  净利润16,333,500.92-74,759,548.26-
  资产减值准备-1,421,832.58-13,137,532.84-
  固定资产和投资性房地产折旧17,667,451.27-35,113,827.88-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧17,667,451.27-35,113,827.88-
  无形资产摊销8,666,376.14-16,391,912.32-
  长期待摊费用摊销584,155.89-1,023,541.51-
  处置固定资产、无形资产和其他长期资产的损失-7,895,012.66--7,507,360.71-
  固定资产报废损失131,459.11-1,405,508.76-
  财务费用11,923,412.63-16,976,345.71-
  投资损失-113,156.56--4,544,279.82-
  递延所得税1,836,311.58--9,914,010.04-
  其中:递延所得税资产减少3,780,677.38--8,001,652.84-
    递延所得税负债增加-1,944,365.8--1,912,357.2-
  存货的减少-16,245,751.85--28,389,460.67-
  经营性应收项目的减少-38,335,457.27--71,137,900.38-
  经营性应付项目的增加17,982,630.83-13,403,710.19-
  其他7,641,952.53-13,480,477.48-
  不涉及现金收支的投资和筹资活动金额其他项目--20,919,180.52-
  现金的期末余额92,397,396.19-149,507,040.96-
  减:现金的期初余额149,507,040.96-131,992,567.98-
  现金及现金等价物的净增加额-57,109,644.77-17,514,472.98-
公告日期2025-08-262025-04-192025-04-152024-10-24
审计意见(境内)标准无保留意见
TOP↑